Difference between revisions of "Team:UiOslo Norway/2"

 
(31 intermediate revisions by the same user not shown)
Line 14: Line 14:
  
 
   .sponsors {
 
   .sponsors {
  display: flex;
 
  flex-direction: row;
 
  flex-wrap: wrap;
 
  justify-content: flex-start;
 
  align-content: center;
 
 
   text-align: center;
 
   text-align: center;
   padding: 0;
+
   }
   max-width: 80%;
+
 
 +
  .sponsors > a {
 +
  width: 300px;
 +
   display: inline-block;
 +
  vertical-align: top;
 +
  margin-bottom: 30px;
 +
  }
 +
 
 +
  .sponsor::after {
 +
  content: "";
 +
  width: 100%;
 +
  display: inline-block;
 
   }
 
   }
  
 
   .logo {
 
   .logo {
 
   height: 50px;
 
   height: 50px;
   width: inherit;
+
   width: auto;
  float: left;
+
  align-self: center;
+
  margin-left: 20px;
+
  margin-right: 20px;
+
 
   }
 
   }
  
Line 53: Line 55:
  
 
<div class="sponsors">
 
<div class="sponsors">
<div>
 
  <a href="https://digitallifenorway.org/gb/">
 
    <img class="logo" src="https://static.igem.org/mediawiki/2018/2/2a/T--UiOslo_Norway--CDL.png" target="_blank" alt="Centre for Digital Life Norway">
 
  </a>
 
</div>
 
  
<div>
+
<a href="https://www.uio.no/english/">
<a href="https://www.biokjemisk.no/">
+
   <img class="logo" src="https://static.igem.org/mediawiki/2018/3/32/T--UiOslo_Norway--UiO.png" target="_blank" alt="University of Oslo">
   <img class="logo" src="https://static.igem.org/mediawiki/2018/e/e2/T--UiOslo_Norway--NBS.png" target="_blank" alt="Norwegian Biochemical Society">
+
 
</a>
 
</a>
</div>
 
  
<div>
 
 
<a href="https://eu.idtdna.com/pages">
 
<a href="https://eu.idtdna.com/pages">
 
   <img class="logo" src="https://static.igem.org/mediawiki/2018/a/ae/T--UiOslo_Norway--IDT.png" target="_blank" alt="Integrated DNA Technologies">
 
   <img class="logo" src="https://static.igem.org/mediawiki/2018/a/ae/T--UiOslo_Norway--IDT.png" target="_blank" alt="Integrated DNA Technologies">
 
</a>
 
</a>
</div>
 
  
<div>
 
 
<a href="https://twistbioscience.com/">
 
<a href="https://twistbioscience.com/">
 
   <img class="logo" src="https://static.igem.org/mediawiki/2018/e/ea/T--UiOslo_Norway--Twist.png" target="_blank" alt="Twist Biosciences">
 
   <img class="logo" src="https://static.igem.org/mediawiki/2018/e/ea/T--UiOslo_Norway--Twist.png" target="_blank" alt="Twist Biosciences">
 
</a>
 
</a>
</div>
 
  
<div>
 
  <a href="https://www.uio.no/english/">
 
    <img class="logo" src="https://static.igem.org/mediawiki/2018/3/32/T--UiOslo_Norway--UiO.png" target="_blank" alt="University of Oslo">
 
  </a>
 
</div>
 
  
<div>
+
<a href="https://digitallifenorway.org/gb/">
  <a href="https://nordicbiosite.com/">
+
  <img class="logo" src="https://static.igem.org/mediawiki/2018/2/2a/T--UiOslo_Norway--CDL.png" target="_blank" alt="Centre for Digital Life Norway">
    <img class="logo" src="https://static.igem.org/mediawiki/2018/b/b0/T--UiOslo_Norway--biosite.png" target="_blank" alt="Nordic BioSite">
+
</a>
  </a>
+
</div>
+
  
<div>
+
<a href="https://www.biokjemisk.no/">
   <a href="https://sharelab.no">
+
   <img class="logo" src="https://static.igem.org/mediawiki/2018/e/e2/T--UiOslo_Norway--NBS.png" target="_blank" alt="Norwegian Biochemical Society">
    <img class="logo" style="background-color: #1f374a; "src="https://static.igem.org/mediawiki/2018/8/87/T--UiOslo_Norway--sharelab.png" target="_blank" alt="Sharelab">
+
</a>
  </a>
+
 
</div>
+
<a href="https://nordicbiosite.com/">
 +
  <img class="logo" src="https://static.igem.org/mediawiki/2018/b/b0/T--UiOslo_Norway--biosite.png" target="_blank" alt="Nordic BioSite">
 +
</a>
 +
 
 +
 
 +
<a href="https://sharelab.no">
 +
  <img class="logo" style="background-color: #1f374a; "src="https://static.igem.org/mediawiki/2018/8/87/T--UiOslo_Norway--sharelab.png" target="_blank" alt="Sharelab">
 +
</a>
 
</div>
 
</div>
  

Latest revision as of 21:44, 16 October 2018

Fast detection of vulvovaginal Candida albicans
infections using CRISPR/dCas9

Concept graphic

UiOslo Norway

During their lifetime 75 % of women will experience a Candida albicans (C. albicans) infection, one of the most common vulvovaginal yeast infections. Currently there are no fast methods to detect whether an infection is caused by C. albicans or not. In addition, women may purchase over-the-counter antimycotics without knowing the cause of their infection. This contributes to the rise of antimycotic resistance, making treatment of future infections more difficult.

Based on previous projects, UiOslo Norway aims to develop a fast detection kit for C. albicans infections, using CRISPR/dCas9. Upon a suspected infection, a vaginal sample will be treated with glucanase to selectively lyse yeast cells walls, exposing the fungal DNA. Afterwards, modified dCas9 enzymes fused with split β-lactamase are added. Using specifically designed guide RNAs, the dCas9 complexes bind adjacently on C. albicans specific DNA sequences. This activates the β-lactamase to cleave its substrate nitrocefin, producing a colored product indicating the presence of C. albicans DNA.